We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ECL:NYSEEcolab Inc. Analysis

Data as of 2026-03-30 - not real-time

$264.75

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Ecolab (ECL) is trading at $264.75, roughly 21% above its DCF‑derived fair value of $141. The stock sits just above its 20‑day SMA of $273.18 and below the 50‑day SMA of $284.89, indicating a modest near‑term pullback. Momentum metrics are mixed: the RSI of 37.8 points to mild oversold conditions, while the MACD remains in a bearish crossover. Support at $252.66 provides a cushion, but the next resistance near $299.88 is still a distance away. On the fundamentals side, revenue grew 17.8% year‑over‑year and EPS is expected to rise to $9.69 forward, reflecting solid top‑line expansion. Recent strategic acquisitions—including the Ovivo water‑solutions deal and the $4.75 B CoolIT Systems purchase—are aimed at strengthening high‑tech water and digital platforms.
The company generates $1.64 B of free cash flow and pays a 1.06% dividend with a modest 36.8% payout ratio, suggesting dividend sustainability. However, a debt‑to‑equity ratio of 104% and a beta near 0.6 signal modest financial leverage and lower market sensitivity. Volatility over the past 30 days sits at 22%, which is higher than the broader market but manageable given the stock’s liquidity. Analysts have upgraded ECL to Buy with a median price target of $326, implying further upside despite the current overvaluation. Given the blend of growth catalysts and a valuation premium, the stock appears overvalued in the short run but offers a compelling growth‑oriented profile. Our recommendation is to hold for the near term, accumulate on dips, and consider a longer‑term position if the acquisitions deliver the projected margin expansion.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and modest upside versus fair value
  • Support level near $252.66 provides downside protection
  • Recent acquisitions still pending integration

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth and EPS expansion outlook
  • Strategic acquisitions targeting high‑margin water solutions
  • Improving free cash flow and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong franchise and recurring revenue streams
  • Dividend sustainability and strong cash generation
  • Long‑term secular demand for water and hygiene solutions

Key Metrics & Analysis

Financial Health

Revenue Growth17.80%
Profit Margin12.91%
P/E Ratio36.3
ROE22.52%
ROA7.84%
Debt/Equity103.92
P/B Ratio11.3
Op. Cash Flow$3.0B
Free Cash Flow$1.6B

Technical Analysis

TrendNeutral
RSI37.8
Support$252.66
Resistance$299.88
MA 20$273.18
MA 50$284.89
MA 200$272.82
MACDBearish
VolumeStable
Fear & Greed Index67.7

Valuation

Fair Value$141.23
Target Price$320.43
Upside/Downside21.03%
GradeOvervalued
TypeGrowth
Dividend Yield1.06%

Risk Assessment

Beta0.58
Volatility22.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.